LUNG CANCER How much platinum-based chemotherapy is enough in NSCLC?

被引：5
|
作者：
Peters, Solange [1 ]
Adjei, Alex A. [2 ]
机构：
[1] CHU Vaudois, Dept Oncol, CH-1011 Lausanne, Switzerland
[2] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2015年 / 12卷 / 01期
关键词：
PHASE-III; RANDOMIZED TRIAL; METAANALYSIS; CISPLATIN; SURVIVAL; DURATION; COURSES; CYCLES;
D O I：
10.1038/nrclinonc.2014.212
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
With no large randomized phase III trials to provide definitive answers, the ideal number of platinum-based chemotherapy cycles in patients with advanced non-small-cell lung cancer has long been unclear. Most guidelines recommend a maximum of 4-6 cycles. Rossi and colleagues now suggest that four chemotherapy cycles is the optimal regimen.
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [21] PROGNOSTIC IMPORTANCE OF RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Radosavljevic, D.
    Kezic, I.
    Jelic, S.
    Golubicic, I.
    ANNALS OF ONCOLOGY, 2008, 19 : 111 - 111
  • [22] Early response to platinum-based chemotherapy in non small cell lung cancer (NSCLC) predicts survival unluike in mesotheliomas
    Sirohi, B
    Matakidou, A
    Benson, C
    Ashley, S
    Priest, K
    Norton, A
    James, M
    Saka, W
    Popat, S
    O'Brien, M
    LUNG CANCER, 2005, 49 : S91 - S91
  • [23] Glutathione pathway pharmacogenomics and response to platinum-based chemotherapy of lung cancer.
    Moyer, A.
    Sun, Z.
    Jenkins, G.
    Batzler, A.
    Hildebrandt, M.
    Schaid, D.
    Yang, P.
    Weinshilboum, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S7 - S7
  • [24] PLATINUM-BASED CHEMOTHERAPY FOR BLADDER-CANCER
    WAXMAN, J
    WASAN, H
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 54 - 60
  • [25] Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy
    Ioannidis, Georgios
    Souglakos, John
    Georgoulias, Vassilis
    LUNG CANCER MANAGEMENT, 2013, 2 (04) : 281 - 293
  • [26] Perioperative nivolumab in combination with platinum-based chemotherapy for stage III lung cancer
    Hekmat, Khosro
    Bruns, Christiane J.
    CHIRURGIE, 2024, 95 (02): : 161 - 162
  • [27] Weight Loss Associated with Platinum-Based Chemotherapy in Patients with Advanced Lung Cancer
    Morio, Kayoko
    Minami, Toshiyuki
    Sozu, Takashi
    Niki, Kazuyuki
    Kijima, Takashi
    Uejima, Etsuko
    CHEMOTHERAPY, 2015, 61 (05) : 256 - 261
  • [28] Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
    Liu, Jia-Si
    Liu, Jun-Yan
    Xiao, Qi
    Li, Xiang-Ping
    Chen, Juan
    Liu, Zhao-Qian
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] Platinum-based chemotherapy, glutathione metabolic pathway genes, and lung cancer survival
    Yang, P
    Williams, B
    Adjei, A
    Sun, Z
    Cunningham, J
    Pankratz, V
    Weinshilboum, R
    LUNG CANCER, 2005, 49 : S22 - S22
  • [30] Treatment of advanced breast cancer: How much chemotherapy is enough?
    Kaufman, A
    SEMINARS IN ONCOLOGY, 1996, 23 (03) : R16 - &
12345